Mia Wadelius
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 51
- Pharmacogenetics and Drug Metabolism 47
-
- Hormonal Regulation and Hypertension 19
- Co-authors
- Munir PirmohamedNiclas ErikssonPanos DeloukasAnders RaneClaes WadeliusTeri E. KleinRalph McGinnisLi Gong
- Journals
- Clinical Pharmacology & Therapeutics (15 papers)Pharmacogenomics (13 papers)The Pharmacogenomics Journal (8 papers)Blood (3 papers)European Journal of Clinical Pharmacology (3 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Mia Wadelius
94 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Pharmacology 4.4k
- Biochemistry 681
- Endocrinology, Diabetes and Metabolism 1.5k
- Internal Medicine 285
- Statistics and Probability 537
Countries citing papers authored by Mia Wadelius
This map shows the geographic impact of Mia Wadelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mia Wadelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mia Wadelius more than expected).
Fields of papers citing papers by Mia Wadelius
This network shows the impact of papers produced by Mia Wadelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mia Wadelius. The network helps show where Mia Wadelius may publish in the future.
Co-authors
The 25 scholars most cited alongside Mia Wadelius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 0 | |
| 6 | 2020 | 40 | |
| 7 | 2020 | 8 | |
| 8 | 2019 | 66 | |
| 9 | 2017 | 8 | |
| 10 | Preventivt arbete kan minska läkemedelsbiverkningar | 2017 | 0 |
| 11 | 2017 | 3 | |
| 12 | Genome-wide scan identifies association between an interferon regulatory factor-related variant and interferon-beta induced liver injury in multiple sclerosis patients | 2016 | 1 |
| 13 | 2013 | 35 | |
| 14 | 2011 | 26 | |
| 15 | Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing Hit paper breakdown → | 2011 | 473 |
| 16 | A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose Hit paper breakdown → | 2009 | 475 |
| 17 | 2008 | 413 | |
| 18 | 2006 | 244 | |
| 19 | 2005 | 99 | |
| 20 | 2002 | 48 |
About Mia Wadelius
Mia Wadelius is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Hematology, Hepatology and Statistics and Probability, having authored 101 papers that have together received 7.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (47 papers), Hormonal Regulation and Hypertension (19 papers), Atrial Fibrillation Management and Outcomes (12 papers), Drug Transport and Resistance Mechanisms (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Blood disorders and treatments (6 papers). The work is most often cited by research in Pharmacology (4.4k citations), Biochemistry (681 citations), Endocrinology, Diabetes and Metabolism (1.5k citations), Internal Medicine (285 citations) and Statistics and Probability (537 citations). Mia Wadelius has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Munir Pirmohamed, Niclas Eriksson, Panos Deloukas, Anders Rane, Claes Wadelius, Teri E. Klein, Ralph McGinnis, Li Gong, Jonatan D. Lindh and Brian F. Gage. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacogenomics, The Pharmacogenomics Journal, Blood and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.